New skin booster injection aims to reverse aging signs

NCT ID NCT07636512

Recruiting now Symptom relief Sponsor: Suisselle Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Cellbooster Shape injections can improve skin aging in 50 healthy adults aged 35 and older. Participants receive three injection sessions over 4 weeks and are followed for 70 days. The study measures skin hydration, elasticity, and appearance, along with safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cellbooster Shape (hyaluronic acid with L-Carnitine and vitamin C)
What this could lead to: If it works, this could offer a safe, non-surgical option to improve skin hydration, elasticity, and reduce puffiness in aging skin.
What could go wrong: This is a small, early-stage study with no comparison group, so results may not be generalizable. Side effects like injection-site reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SKIN AGING

Contacts and locations

Locations

Eurofins Dermscan Pharmascan
RECRUITING

Villeurbanne, 69100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.